Bio-FD&C Co. Ltd.
BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, natural extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, acne, skin irritation, wound healing, scalp improvement, skin moisturizing, fine dust, hair loss improvement, pores, lifting, whitening, skin texture, anti-inflammation/skin soot… Read more
Bio-FD&C Co. Ltd. (251120) - Total Liabilities
Latest total liabilities as of September 2025: ₩3.80 Billion KRW
Based on the latest financial reports, Bio-FD&C Co. Ltd. (251120) has total liabilities worth ₩3.80 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bio-FD&C Co. Ltd. - Total Liabilities Trend (2018–2024)
This chart illustrates how Bio-FD&C Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bio-FD&C Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Bio-FD&C Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PADAUK Technology Co. Ltd
TWO:6716
|
Taiwan | NT$401.85 Million |
|
Carnaby Resources Ltd
AU:CNB
|
Australia | AU$10.04 Million |
|
Citizens Bancshares Corp
PINK:CZBS
|
USA | $613.64 Million |
|
MAIA Biotechnology Inc.
NYSE MKT:MAIA
|
USA | $11.74 Million |
|
Ratnaveer Precision Engineering Ltd
NSE:RATNAVEER
|
India | ₹5.10 Billion |
|
Leo Lithium Limited
PINK:LLLAF
|
USA | $8.07 Million |
|
Plastron Precision Co Ltd
TWO:6185
|
Taiwan | NT$345.06 Million |
|
Ramayana Lestari Sentosa Tbk
JK:RALS
|
Indonesia | Rp988.95 Billion |
Liability Composition Analysis (2018–2024)
This chart breaks down Bio-FD&C Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 16.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bio-FD&C Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bio-FD&C Co. Ltd. (2018–2024)
The table below shows the annual total liabilities of Bio-FD&C Co. Ltd. from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩4.18 Billion | -0.27% |
| 2023-12-31 | ₩4.20 Billion | -30.75% |
| 2022-12-31 | ₩6.06 Billion | -15.35% |
| 2021-12-31 | ₩7.16 Billion | +37.60% |
| 2020-12-31 | ₩5.20 Billion | -2.36% |
| 2019-12-31 | ₩5.33 Billion | +6.42% |
| 2018-12-31 | ₩5.01 Billion | -- |